Edvard Cock has, as chairman of the Board of Directors of Aqua Bio Technology ASA, received proxies to vote for 5,735,037 shares at the extraordinary general meeting on 27 June 2019 (the "EGM") without any voting instructions, representing approx. 48.77 % of the total shares and votes in the company. The proxies received are only valid for the EGM and will lapse automatically thereafter.
Further, Blixen Invest AS, a company wholly-owned by Edvard Cock, holds 500,000 shares in Aqua Bio Technology, and together with the received proxies, Edvard Cock may therefore vote for 6,235,037 shares, representing approx. 53.02 % of the votes in the company.
This information is subject to disclosure pursuant to section 4-3 of the Norwegian Securities Trading Act.